BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Bio NC

  Honeywell Teams With Astrazeneca To Develop Next-Generation Respiratory Inhalers That Use Near-Zero Global Warming Potential Propellant

  Honeywell announced a commercial partnership with AstraZeneca to develop and bring to market next-generation respiratory inhalers that use near-zero global warming potential propellants to treat asthma and chronic obstructive pulmonary disease.

  February 22, 2022

   · 

  6 min read
• XNK Therapeutics to present at Redeye’s Regenerative Medicine/Cell Therapy event on February 23

  XNK Therapeutics AB’s CEO Johan Liwing will present at Redeye’s Regenerative Medicine/Cell Therapy event on February 23 at 09.50 CET.

  February 22, 2022

   · 

  1 min read
• Medivir to present at the Erik Penser Bank Health Care Day

  Medivir AB announces that its new CEO Jens Lindberg will participate at the Erik Penser Bank Health Care Day, Thursday February 24, 2022.

  February 22, 2022

   · 

  1 min read
• Northern Ireland goes live with pathology solution from Sectra--joins together radiology and pathology images

  Northern Ireland becomes the first UK region to combine pathology and radiology images and reports in the same medical imaging system.

  February 22, 2022

   · 

  5 min read
• Philips publishes its Annual Report 2021

  Royal Philips, a global leader in health technology, published its Annual Report 2021.

  February 22, 2022

   · 

  2 min read
• Cumulus Oncology Secures £4.1m ($5.6m) Investment Led by Eos Advisory

  Cumulus Oncology, Europe’s first oncology biotech creation company, has secured a £4.1 million investment led by St Andrews-based investment firm Eos Advisory.

  February 22, 2022

   · 

  3 min read
• Business

  111 to Announce Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results on March 17, 2022 - Conference Call to Follow

  111, Inc. today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2021 ended December 31, 2021 , before the U.S. market opens on Thursday, March 17, 2022.

  February 22, 2022

   · 

  2 min read
• Immunovia invited to the 42nd Annual Cowen Health Care Conference

  Immunovia will participate in the Cowen 42nd Annual Health Care Virtual Conference on March 9, 2022.

  February 22, 2022

   · 

  2 min read
• Job Trends

  RosVivo Therapeutics, Inc. signed a Material Transfer Agreement (MTA) for first-in-class diabetes treatment with Eli Lilly and Company

  RosVivo Therapeutics, Inc. announced that it has signed a Material Transfer Agreement with one of the largest global pharmaceutical companies Eli Lilly and Company for commercial development of diabetes and obesity treatments.

  February 22, 2022

   · 

  2 min read
• Drug Development

  InnoCare Announces Dosing of First Patient in Phase II Clinical Trial Using Orelabrutinib for the Treatment of ITP

  InnoCare Pharma, a leading biopharmaceutical company, announced that the first patient has been dosed in Phase II clinical trial of its Bruton’s tyrosine kinase inhibitor orelabrutinib for the treatment of primary immune thrombocytopenia in China.

  February 22, 2022

   · 

  3 min read